News

Unilife Corporation has launched Unitract.com to support the commercial release of its Unitract 1 mL clinical safety syringes.

The Food and Drug Administration (FDA) has approved vaccines for the 2010-2011 influenza season in the United States.

A new drug-resistant strain of E. coli, ST131, is a major cause of serious antimicrobial-resistant E. coli infections in the United States.

Researchers show that public education campaigns regarding hand hygiene are effective in altering individual hand hygiene habits during the peak periods of influenza transmission.

When Staphylococcus aureus is isolated in urine, it is thought to usually represent hematogenous spread. Because such spread might have special clinical significance, Shingo Chihara and colleagues evaluated predictors and outcomes of S. aureus bacteriuria among patients with S. aureus bacteremia.

Epidemic outbreaks of multidrug-resistant (MDR) Acinetobacter baumannii (AB) in intensive care units (ICUs) are increasing. The incidence of MDR-AB bacteremia, which develops as a result of colonization, is increasing through widespread dissemination of the pathogen, and further colonization.

During the SARS pandemic in Hong Kong, panic and worry were prevalent in the community and the general public avoided staying in public areas.

Sanofi Pasteur announces that shipping of the 2010-2011 formulation of its seasonal influenza vaccine Fluzone® Influenza Virus Vaccine is underway in the U.S.

Researchers have discovered a novel mechanism in Salmonella that affects its virulence and its susceptibility to antibiotics by changing its production of proteins in a previously unheard of manner. This allows Salmonella to selectively change its levels of certain proteins to respond to inhospitable conditions.

A new research consortium through which to address persistent knowledge gaps could be precisely what the healthcare epidemiology and infection prevention community has been waiting for in light of urgent scientific and clinical questions requiring more definitive answers

Electronic portal speeds identification and investigation of potential health hazards in human food industry.

The best way to prevent the spread of disease in rural areas may be by targeting select popular hangouts, according to a new study by the Kansas State University EpiCenter research team.

Vaccine scares may do more harm than previously believed to a population's "herd immunity."

Researcher discovers existing drugs can potentially target the disease's ability to spread.

New research shows that individuals with mild H1N1 infection may go undetected using standard diagnostic criteria.

The Natural Resources Defense Council (NRDC) says it has filed a lawsuit against the Food and Drug Administration (FDA) for failing to issue a final rule regulating the chemicals triclosan and triclocarban, which are commonly found in antibacterial soaps.

Delivery to the Strategic National Stockpile of the first 1 million doses of the nations first smallpox vaccine for certain immune-compromised populations is now complete, the result of a Project BioShield contract.

Thermo Fisher Scientific Inc. announces today that it has received Food and Drug Administration (FDA) clearance for Spectra VRE, a test designed to screen for vancomycin-resistant Enterococcus (VRE).

Healthcare-associated catheter-related bloodstream infections (HA-BSIs) remain a major cause of morbidity and mortality in the U.S.

Media reports of outbreaks and infections caused by unsafe injection practices in healthcare facilities especially in outpatient settings seem to confirm the Centers for Disease Control and Prevention (CDC) statistics that since 1999, more than 125,000 U.S. patients have received letters alerting them of potential exposure to infection with hepatitis viruses or human immunodeficiency virus (HIV) due to unsafe injection practices such as the reuse of syringes.

ICT turned to members of industry to determine what they believe is the single most important thing that clinicians can do to prevent needlesticks, sharps injuries and other percutaneous injuries. They also share how their technology helps prevent these types of injuries.

Dynavax Technologies Corporation reports that enrollment and the first immunizations of 39 subjects enrolled in its Phase 1 study of the company's universal flu vaccine have been completed.

Researchers have found that an enzyme in the bacteria that causes cholera uses a previously unknown mechanism in providing the bacteria with energy.

As bed turn rates decline, the summer months give environmental service departments time to recharge and prepare for the next flu season.

Pharmacy OneSource announces a complimentary Webinar, "New Research on Preventing Hospital Infection," presented by Betsy McCaughey, PhD.

The Association for Professionals in Infection Control and Epidemiology (APIC) is offering its Professional Development Webinar Series, "The Power of Influence," as two Webinars to be held in August.